DXCM logo

DexCom (DXCM) Company Overview

Profile

Full Name:

DexCom, Inc.

Sector:

Healthcare

Country:

United States

IPO:

April 14, 2005

Description:

DexCom, Inc. is a company specializing in the development and production of medical equipment with headquarters in San Diego, California. It is mainly involved in the development and implementation of devices for continuous glucose monitoring (CGMS) in patients with diabetes. It was founded in 1999. The company's product portfolio includes DexCom G6 and DexCom G6 Pro (the first integrated type of CGMS approved by the FDA for use with other compatible medical devices and electronic interfaces), DexCom G5 Mobile (which allows the company's transmitter to run Software 505 algorithm and directly connect to the patient's compatible mobile device, including iPhone, iPod touch, iPad, and some Android devices), DexCom G4 PLATINUM, and DexCom Share.

Key Details

Price

$73.50

Annual Revenue

$4.03 B(+11.34% YoY)

Annual EPS

$1.42(+9.23% YoY)

Beta

0.46

Events Calendar

Earnings

Next earnings date:

Apr 25, 2025

Recent quarterly earnings:

Feb 13, 2025

Recent annual earnings:

Feb 13, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jun 13, 2022

Analyst ratings

Recent major analysts updates

Mar 4, 25 Citigroup
Buy
Feb 14, 25 Morgan Stanley
Equal-Weight
Feb 14, 25 Canaccord Genuity
Buy
Feb 3, 25 Redburn Atlantic
Buy
Jan 16, 25 Baird
Outperform
Dec 11, 24 Wells Fargo
Overweight
Dec 11, 24 Citigroup
Buy
Dec 9, 24 Canaccord Genuity
Buy
Oct 25, 24 Wells Fargo
Overweight
Oct 25, 24 Raymond James
Strong Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for DexCom?
  • Does DexCom pay dividends?
  • What sector is DexCom in?
  • What industry is DexCom in?
  • What country is DexCom based in?
  • When did DexCom go public?
  • Is DexCom in the S&P 500?
  • Is DexCom in the NASDAQ 100?
  • Is DexCom in the Dow Jones?
  • When was DexCom's last earnings report?
  • When does DexCom report earnings?
  • Should I buy DexCom stock now?

What is the ticker symbol for DexCom?

The ticker symbol for DexCom is NASDAQ:DXCM

Does DexCom pay dividends?

No, DexCom does not pay dividends

What sector is DexCom in?

DexCom is in the Healthcare sector

What industry is DexCom in?

DexCom is in the Medical Devices industry

What country is DexCom based in?

DexCom is headquartered in United States

When did DexCom go public?

DexCom's initial public offering (IPO) was on April 14, 2005

Is DexCom in the S&P 500?

Yes, DexCom is included in the S&P 500 index

Is DexCom in the NASDAQ 100?

Yes, DexCom is included in the NASDAQ 100 index

Is DexCom in the Dow Jones?

No, DexCom is not included in the Dow Jones index

When was DexCom's last earnings report?

DexCom's most recent earnings report was on Feb 13, 2025

When does DexCom report earnings?

The next expected earnings date for DexCom is Apr 25, 2025

Should I buy DexCom stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions